Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance.

Adele Chimento, Maria D'Amico, Vincenzo Pezzi, Francesca De Amicis

International journal of molecular sciences 2022 Jun 04

filter terms:

Notch signaling dysregulation encourages breast cancer progression through different mechanisms such as stem cell maintenance, cell proliferation and migration/invasion. Furthermore, Notch is a crucial driver regulating juxtracrine and paracrine communications between tumor and stroma. The complex interplay between the abnormal Notch pathway orchestrating the activation of other signals and cellular heterogeneity contribute towards remodeling of the tumor microenvironment. These changes, together with tumor evolution and treatment pressure, drive breast cancer drug resistance. Preclinical studies have shown that targeting the Notch pathway can prevent or reverse resistance, reducing or eliminating breast cancer stem cells. In the present review, we will summarize the current scientific evidence that highlights the involvement of Notch activation within the breast tumor microenvironment, angiogenesis, extracellular matrix remodeling, and tumor/stroma/immune system interplay and its involvement in mechanisms of therapy resistance.

Citation

Adele Chimento, Maria D'Amico, Vincenzo Pezzi, Francesca De Amicis. Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance. International journal of molecular sciences. 2022 Jun 04;23(11)